We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Topics » COVID-19

COVID-19
COVID-19 RSS Feed RSS

Merck’s COVID-19 Pill Cuts Risk of Death and Hastens Recovery

June 9, 2022
Merck’s COVID-19 pill Lagevrio (molnupiravir) not only reduced the risk of hospitalization or death in patients with mild-to-moderate COVID-19 by 32.1 percent, it also reduced the chance of needing acute care visits for weeks after treatment ended, researchers reported in the Annals of Internal Medicine. Read More

Veru Submits EUA for Treatment of COVID-19 Hospitalized Patients

June 9, 2022
Sabizabulin demonstrated a 55.2 percent reduction in deaths relative to the untreated cohort. Read More

Moderna’s COVID-19 Bivalent Booster Shows Efficacy Against Omicron in Study

June 9, 2022
Moderna anticipates that the Omicron-specific booster will be available in the late summer. Read More

FDA Advisory Committee Recommends Novavax’s COVID-19 Vaccine

June 8, 2022
The FDA’s Vaccines and Related Biological Products Advisory Committee voted almost unanimously yesterday for Emergency Use Authorization (EUA) of a two-dose primary series of the Novavax COVID-19 vaccine. Read More

J&J to Drop Emergent After Mutual Claims of Contract Breach

June 8, 2022
Johnson & Johnson (J&J) is pulling out of its COVID-19 vaccine supply contract with the troubled drug manufacturing plant, Emergent BioSolutions. Read More

Trinity Biotech Gains CE Mark for 10-Minute COVID-19 Antigen Test

June 7, 2022
The test uses anterior nasal swab samples rather than the more invasive nasopharangeal swabs. Read More

Nanomix Receives a CE Mark for Its eLab COVID-19 Rapid Point-of-Care Antigen Panel

June 7, 2022
The portable eLab system provides “results comparable in quality to those provided by central lab testing,” the company said. Read More

FDA Committee to Review Novavax’s EUA Application for Its COVID-19 Vaccine

June 6, 2022
Novavax goes before FDA’s Vaccines and Related Biologics Advisory Committee this week, seeking Emergency Use Authorization of its COVID-19 vaccine. Read More

Nexus’s COVID-19 Test Kit Gets FDA’s Emergency Use Authorization

June 3, 2022
Test analysis is limited to the Aldatu Diagnostics laboratory in Watertown, Mass. Read More

Gemina Labs Gets CE Mark for Its Legio-X COVID-19 Rapid Antigen Test

May 27, 2022
Gemina plans to launch the COVID-19 test in Europe in the second half of 2022. Read More

Pfizer to Expand Its Largest Manufacturing Site to Increase Paxlovid Supply

May 26, 2022
Pfizer said it will announce the project’s cost and timeline in early June. Read More

Pfizer/BioNTech COVID-19 Vaccine Shows Promising Results in Children Under Five

May 24, 2022
Pfizer and BioNTech expect to complete their EUA submission of their COVID-19 vaccine for kids under five this week. Read More
Previous 1 2 3 4 5 6 7 8 9 … 167 168 Next

Upcoming Events

  • 28Jun

    Effective Root Cause Analysis and CAPA Investigations for the Life Sciences

  • 13Jul

    FDA Ad and Promo Enforcement Trends: Past, Present and Future

  • 28Jul

    EU-MDR’s Growing Pains: Are You Current with the Latest Developments?

  • 28Jul

    Is Your Product a Drug or Device — and Does It Matter?: A Recent Appeals Court Decision Says It Does

  • 02Aug

    Medical Device Cybersecurity: Understand the Latest Developments

  • 03Aug

    Pharmaceutical Process Validation: Best Practices for Success

Featured Products

  • FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

    FDA’s New Quality System Regulation: Transitioning from QSR to ISO 13485

  • Selecting and Implementing Electronic Document Management Systems in the EU

    Selecting and Implementing Electronic Document Management Systems in the EU

Featured Stories

  • Okami Medical’s LOBO-7 and LOBO-9 Vascular Occluders Cleared

  • FDA Puts Clinical Hold on Astellas Late-Onset Pompe Disease Clinical Trial

  • FDA Provides Update on GE Healthcare’s Recall of Its Carescape R860 Ventilators

  • Gilead Resubmits NDA for Lenacapavir Following Complete Response Letter

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing